Gottlieb, Robert L.
Hall, Shelley A.
Article History
First Online: 10 April 2018
Compliance with Ethical Standards
:
: Robert Gottlieb reports participation in the National Consortium Trial, TROJAN-C (Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis C Heart Recipients, NCT03383419). TROJAN-C is receiving pharmaceutical supplies from Gilead Pharmaceuticals, USA. This investigator-initiated trial is sponsored independently by Baylor Scott & White Research Institute. Gilead is not the study sponsor, is not responsible for either the conduct or the design of the trial, and is providing the study drug only. This relationship is disclosed as a potential conflict of interest nonetheless. Shelley Hall reports non-financial support from Gilead, outside the submitted work.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).